Skip to main content
Top
Published in: Inflammation Research 12/2011

01-12-2011 | Original Research Paper

Systematic analysis of histamine and N-methylhistamine concentrations in organs from two common laboratory mouse strains: C57Bl/6 and Balb/c

Authors: Anna Sophie Zimmermann, Heike Burhenne, Volkhard Kaever, Roland Seifert, Detlef Neumann

Published in: Inflammation Research | Issue 12/2011

Login to get access

Abstract

Objective

Histamine plays a role in several (patho) physiological processes that are commonly studied in mouse models. However, a systematic quantification of histamine and its metabolite N-methylhistamine in mouse organs has not been reported so far.

Methods

Balb/c and C57Bl/6 mice were grouped according to their sex and age. Brains, hearts, lungs, livers, kidneys, stomachs, intestines, thymi, spleens, and lymph nodes were excised, weighed, and homogenized. Histamine and N-methylhistamine were quantified simultaneously by a HPLC-mass spectrometry method.

Results

In all organs analyzed, histamine and N-methylhistamine were detected; however, with quantitative differences. Histamine was present most abundantly in the stomach, lymph nodes, and thymus. The lowest histamine concentrations were detected in brain, liver, lung, and intestine. In most organs, the histamine concentrations increased age-dependently. Substantial concentrations of N-methylhistamine were detected only in lung, intestine and kidney, while in all other organs it was present only in minor quantities.

Conclusion

HPLC-mass spectrometry is a useful method for the highly sensitive and simultaneous detection of histamine and N-methylhistamine. Histamine is present in virtually all organs, not only in those traditionally associated with histamine-mediated disease. Highest concentrations are found in stomach, lymph node, and thymus; medium concentrations in heart, spleen, and kidney; and lowest concentrations detected in intestine, brain, liver, and lung.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bakker RA, Timmerman H, Leurs R. Histamine receptors: specific ligands, receptor biochemistry, and signal transduction. Clin Allergy Immunol. 2002;17:27–64.PubMed Bakker RA, Timmerman H, Leurs R. Histamine receptors: specific ligands, receptor biochemistry, and signal transduction. Clin Allergy Immunol. 2002;17:27–64.PubMed
2.
go back to reference Jutel M, Akdis M, Akdis CA. Histamine, histamine receptors and their role in immune pathology. Clin Exp Allergy. 2009;39:1786–800.PubMedCrossRef Jutel M, Akdis M, Akdis CA. Histamine, histamine receptors and their role in immune pathology. Clin Exp Allergy. 2009;39:1786–800.PubMedCrossRef
3.
go back to reference Thurmond R, Gelfand E, Dunford P. The role of histamine H1 and H4 receptors in allergic inflammation: the search for new antihistamines. Nat Rev Drug Discov. 2008;7:41–53.PubMedCrossRef Thurmond R, Gelfand E, Dunford P. The role of histamine H1 and H4 receptors in allergic inflammation: the search for new antihistamines. Nat Rev Drug Discov. 2008;7:41–53.PubMedCrossRef
4.
go back to reference Schubert ML, Peura DA. Control of gastric acid secretion in health and disease. Gastroenterology. 2008;134:1842–60.PubMedCrossRef Schubert ML, Peura DA. Control of gastric acid secretion in health and disease. Gastroenterology. 2008;134:1842–60.PubMedCrossRef
5.
go back to reference Masaki T, Yoshimatsu H. Neuronal histamine and its receptors: implication of the pharmacological treatment of obesity. Curr Med Chem. 2010;17:4587–92.PubMedCrossRef Masaki T, Yoshimatsu H. Neuronal histamine and its receptors: implication of the pharmacological treatment of obesity. Curr Med Chem. 2010;17:4587–92.PubMedCrossRef
6.
go back to reference Huang J, Thurmond R. The new biology of histamine receptors. Curr Allergy Asthma Rep. 2008;8:21–7.PubMedCrossRef Huang J, Thurmond R. The new biology of histamine receptors. Curr Allergy Asthma Rep. 2008;8:21–7.PubMedCrossRef
7.
go back to reference Seifert R, Wenzel-Seifert K. Constitutive activity of G-protein-coupled receptors: cause of disease and common property of wild-type receptors. Naunyn Schmiedebergs Arch Pharmacol. 2002;366:381–416.PubMedCrossRef Seifert R, Wenzel-Seifert K. Constitutive activity of G-protein-coupled receptors: cause of disease and common property of wild-type receptors. Naunyn Schmiedebergs Arch Pharmacol. 2002;366:381–416.PubMedCrossRef
8.
go back to reference Gesler RM, Matsuba M. An experimental design for the biological assay of histamine using the guinea pig ileum. J Pharmacol Exp Ther. 1955;114:151–9.PubMed Gesler RM, Matsuba M. An experimental design for the biological assay of histamine using the guinea pig ileum. J Pharmacol Exp Ther. 1955;114:151–9.PubMed
9.
go back to reference Shore PA, Burkhalter A, Cohn VH. A method for the fluorometric assay of histamine in tissues. J Pharmacol Exp Ther. 1959;127:182–6.PubMed Shore PA, Burkhalter A, Cohn VH. A method for the fluorometric assay of histamine in tissues. J Pharmacol Exp Ther. 1959;127:182–6.PubMed
10.
go back to reference Hammar E, Berglund A, Hedin A, Norrman A, Rustas K, Ytterström U, et al. An immunoassay for histamine based on monoclonal antibodies. J Immunol Methods. 1990;128:51–8.PubMedCrossRef Hammar E, Berglund A, Hedin A, Norrman A, Rustas K, Ytterström U, et al. An immunoassay for histamine based on monoclonal antibodies. J Immunol Methods. 1990;128:51–8.PubMedCrossRef
11.
go back to reference Mita H, Yasueda H, Shida T. Quantitative analysis of histamine in biological samples by gas chromatography–mass spectrometry. J Chromatogr. 1980;181:153–9.PubMedCrossRef Mita H, Yasueda H, Shida T. Quantitative analysis of histamine in biological samples by gas chromatography–mass spectrometry. J Chromatogr. 1980;181:153–9.PubMedCrossRef
12.
go back to reference Maintz L, Novak N. Histamine and histamine intolerance. Am J Clin Nutr. 2007;85:1185–96.PubMed Maintz L, Novak N. Histamine and histamine intolerance. Am J Clin Nutr. 2007;85:1185–96.PubMed
13.
go back to reference Huetz GN, Schwelberger HG. Simultaneous purification of the histamine degrading enzymes diamine oxidase and histamine N-methyltransferase from the same tissue. Inflamm Res. 2003;52(Suppl 1):S65–6.PubMedCrossRef Huetz GN, Schwelberger HG. Simultaneous purification of the histamine degrading enzymes diamine oxidase and histamine N-methyltransferase from the same tissue. Inflamm Res. 2003;52(Suppl 1):S65–6.PubMedCrossRef
14.
go back to reference Burtin C, Scheinmann P, Paupe J, Canu P, Goy J. Tissue histamine levels in male and female normal and nude mice. Agents Actions. 1982;12:199–200.PubMedCrossRef Burtin C, Scheinmann P, Paupe J, Canu P, Goy J. Tissue histamine levels in male and female normal and nude mice. Agents Actions. 1982;12:199–200.PubMedCrossRef
15.
go back to reference Maeyama K, Watanabe T, Taguchi Y, Yamatodani A, Wada H. Effect of alpha-fluoromethylhistidine, a suicide inhibitor of histidine decarboxylase, on histamine levels in mouse tissues. Biochem Pharmacol. 1982;31:2367–70.PubMedCrossRef Maeyama K, Watanabe T, Taguchi Y, Yamatodani A, Wada H. Effect of alpha-fluoromethylhistidine, a suicide inhibitor of histidine decarboxylase, on histamine levels in mouse tissues. Biochem Pharmacol. 1982;31:2367–70.PubMedCrossRef
16.
go back to reference Raica M, Cimpean AM, Nico B, Guidolin D, Ribatti D. A comparative study of the spatial distribution of mast cells and microvessels in the foetal, adult human thymus and thymoma. Int J Exp Pathol. 2010;91:17–23.PubMedCrossRef Raica M, Cimpean AM, Nico B, Guidolin D, Ribatti D. A comparative study of the spatial distribution of mast cells and microvessels in the foetal, adult human thymus and thymoma. Int J Exp Pathol. 2010;91:17–23.PubMedCrossRef
17.
go back to reference Raica M, Cîmpean AM, Encică S, Scridon T, Bârsan M. Increased mast cell density and microvessel density in the thymus of patients with myasthenia gravis. Rom J Morphol Embryol. 2007;48:11–6.PubMed Raica M, Cîmpean AM, Encică S, Scridon T, Bârsan M. Increased mast cell density and microvessel density in the thymus of patients with myasthenia gravis. Rom J Morphol Embryol. 2007;48:11–6.PubMed
18.
go back to reference Csaba G, Kovács P. Perinuclear localization of biogenic amines (serotonin and histamine) in rat immune cells. Cell Biol Int. 2006;30:861–5.PubMedCrossRef Csaba G, Kovács P. Perinuclear localization of biogenic amines (serotonin and histamine) in rat immune cells. Cell Biol Int. 2006;30:861–5.PubMedCrossRef
19.
go back to reference Ginsburg H, Nir I, Hammel I, Eren R, Weissman BA, Naot Y. Differentiation and activity of mast cells following immunization in cultures of lymph-node cells. Immunology. 1978;35:485–502.PubMed Ginsburg H, Nir I, Hammel I, Eren R, Weissman BA, Naot Y. Differentiation and activity of mast cells following immunization in cultures of lymph-node cells. Immunology. 1978;35:485–502.PubMed
20.
go back to reference Musio S, Gallo B, Scabeni S, Lapilla M, Poliani PL, Matarese G, et al. A key regulatory role for histamine in experimental autoimmune encephalomyelitis: disease exacerbation in histidine decarboxylase-deficient mice. J Immunol. 2006;176:17–26.PubMed Musio S, Gallo B, Scabeni S, Lapilla M, Poliani PL, Matarese G, et al. A key regulatory role for histamine in experimental autoimmune encephalomyelitis: disease exacerbation in histidine decarboxylase-deficient mice. J Immunol. 2006;176:17–26.PubMed
21.
go back to reference Jawdat DM, Albert EJ, Rowden G, Haidl ID, Marshall JS. IgE-mediated mast cell activation induces Langerhans cell migration in vivo. J Immunol. 2004;173:5275–82.PubMed Jawdat DM, Albert EJ, Rowden G, Haidl ID, Marshall JS. IgE-mediated mast cell activation induces Langerhans cell migration in vivo. J Immunol. 2004;173:5275–82.PubMed
22.
go back to reference Tomita M, Matsuzaki Y, Onitsuka T. Correlation between mast cells and survival rates in patients with pulmonary adenocarcinoma. Lung Cancer. 1999;26:103–8.PubMedCrossRef Tomita M, Matsuzaki Y, Onitsuka T. Correlation between mast cells and survival rates in patients with pulmonary adenocarcinoma. Lung Cancer. 1999;26:103–8.PubMedCrossRef
23.
go back to reference Tomita M, Matsuzaki Y, Edagawa M, Shimizu T, Hara M, Onitsuka T. Distribution of mast cells in mediastinal lymph nodes from lung cancer patients. World J Surg Oncol. 2003;1:25.PubMedCrossRef Tomita M, Matsuzaki Y, Edagawa M, Shimizu T, Hara M, Onitsuka T. Distribution of mast cells in mediastinal lymph nodes from lung cancer patients. World J Surg Oncol. 2003;1:25.PubMedCrossRef
24.
go back to reference Man WK, Li SK, Spencer J, Baron JH, Michalowski AS. Gastrointestinal histamine and histamine formation capacity after gastric irradiation in mice. Br J Radiol. 1990;63:209–13.PubMedCrossRef Man WK, Li SK, Spencer J, Baron JH, Michalowski AS. Gastrointestinal histamine and histamine formation capacity after gastric irradiation in mice. Br J Radiol. 1990;63:209–13.PubMedCrossRef
25.
go back to reference Aschenbach JR, Honscha KU, von Vietinghoff V, Gäbel G. Bioelimination of histamine in epithelia of the porcine proximal colon of pigs. Inflamm Res. 2009;58:269–76.PubMedCrossRef Aschenbach JR, Honscha KU, von Vietinghoff V, Gäbel G. Bioelimination of histamine in epithelia of the porcine proximal colon of pigs. Inflamm Res. 2009;58:269–76.PubMedCrossRef
26.
go back to reference Kuefner MA, Schwelberger HG, Hahn EG, Raithel M. Decreased histamine catabolism in the colonic mucosa of patients with colonic adenoma. Dig Dis Sci. 2008;53:436–42.PubMedCrossRef Kuefner MA, Schwelberger HG, Hahn EG, Raithel M. Decreased histamine catabolism in the colonic mucosa of patients with colonic adenoma. Dig Dis Sci. 2008;53:436–42.PubMedCrossRef
27.
go back to reference Fogel WA, Dastych J, Maśliński C. The response of histamine degrading enzymes to nematode infection. Agents Actions. 1988;23:304–6.PubMedCrossRef Fogel WA, Dastych J, Maśliński C. The response of histamine degrading enzymes to nematode infection. Agents Actions. 1988;23:304–6.PubMedCrossRef
28.
go back to reference Shinagawa K, Kojima M. Mouse model of airway remodeling: strain differences. Am J Respir Crit Care Med. 2003;168:959–67.PubMedCrossRef Shinagawa K, Kojima M. Mouse model of airway remodeling: strain differences. Am J Respir Crit Care Med. 2003;168:959–67.PubMedCrossRef
29.
go back to reference Prescott VE, Hogan SP. Genetically modified plants and food hypersensitivity diseases: usage and implications of experimental models for risk assessment. Pharmacol Ther. 2006;111:374–83.PubMedCrossRef Prescott VE, Hogan SP. Genetically modified plants and food hypersensitivity diseases: usage and implications of experimental models for risk assessment. Pharmacol Ther. 2006;111:374–83.PubMedCrossRef
30.
go back to reference Aviado DM, Sadavongvivad C. Pharmacological significance of biogenic amines in the lungs: histamine. Br J Pharmacol. 1970;38:366–73.PubMed Aviado DM, Sadavongvivad C. Pharmacological significance of biogenic amines in the lungs: histamine. Br J Pharmacol. 1970;38:366–73.PubMed
31.
go back to reference Douglas JS, Duncan PG. Characterisation of textile dust extracts: I. Histamine release in vitro. Br J Ind Med. 1984;41:64–9.PubMed Douglas JS, Duncan PG. Characterisation of textile dust extracts: I. Histamine release in vitro. Br J Ind Med. 1984;41:64–9.PubMed
32.
go back to reference Hartwig C, Constabel H, Neumann D, Gerd Hoymann H, Tschernig T, Behrens G. Impact of boostering for the strength of asthma parameters and dendritic cell numbers in a C57BL/6 model of allergic airway inflammation. Exp Toxicol Pathol. 2008;60:425–34.PubMedCrossRef Hartwig C, Constabel H, Neumann D, Gerd Hoymann H, Tschernig T, Behrens G. Impact of boostering for the strength of asthma parameters and dendritic cell numbers in a C57BL/6 model of allergic airway inflammation. Exp Toxicol Pathol. 2008;60:425–34.PubMedCrossRef
33.
go back to reference Sedor JR, Abboud HE. Actions and metabolism of histamine in glomeruli and tubules of the human kidney. Kidney Int. 1984;26:144–52.PubMedCrossRef Sedor JR, Abboud HE. Actions and metabolism of histamine in glomeruli and tubules of the human kidney. Kidney Int. 1984;26:144–52.PubMedCrossRef
Metadata
Title
Systematic analysis of histamine and N-methylhistamine concentrations in organs from two common laboratory mouse strains: C57Bl/6 and Balb/c
Authors
Anna Sophie Zimmermann
Heike Burhenne
Volkhard Kaever
Roland Seifert
Detlef Neumann
Publication date
01-12-2011
Publisher
SP Birkhäuser Verlag Basel
Published in
Inflammation Research / Issue 12/2011
Print ISSN: 1023-3830
Electronic ISSN: 1420-908X
DOI
https://doi.org/10.1007/s00011-011-0379-5

Other articles of this Issue 12/2011

Inflammation Research 12/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine